1. Home
  2. TMDX vs RNST Comparison

TMDX vs RNST Comparison

Compare TMDX & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • RNST
  • Stock Information
  • Founded
  • TMDX 1998
  • RNST 1904
  • Country
  • TMDX United States
  • RNST United States
  • Employees
  • TMDX N/A
  • RNST N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RNST Major Banks
  • Sector
  • TMDX Health Care
  • RNST Finance
  • Exchange
  • TMDX Nasdaq
  • RNST Nasdaq
  • Market Cap
  • TMDX 2.3B
  • RNST 2.2B
  • IPO Year
  • TMDX 2019
  • RNST N/A
  • Fundamental
  • Price
  • TMDX $68.58
  • RNST $33.74
  • Analyst Decision
  • TMDX Buy
  • RNST Buy
  • Analyst Count
  • TMDX 10
  • RNST 6
  • Target Price
  • TMDX $118.44
  • RNST $43.60
  • AVG Volume (30 Days)
  • TMDX 929.2K
  • RNST 689.1K
  • Earning Date
  • TMDX 04-29-2025
  • RNST 04-22-2025
  • Dividend Yield
  • TMDX N/A
  • RNST 2.62%
  • EPS Growth
  • TMDX N/A
  • RNST 27.73
  • EPS
  • TMDX 1.01
  • RNST 3.27
  • Revenue
  • TMDX $441,540,000.00
  • RNST $706,583,000.00
  • Revenue This Year
  • TMDX $25.24
  • RNST $35.54
  • Revenue Next Year
  • TMDX $19.89
  • RNST $20.29
  • P/E Ratio
  • TMDX $67.90
  • RNST $10.71
  • Revenue Growth
  • TMDX 82.74
  • RNST 14.55
  • 52 Week Low
  • TMDX $55.00
  • RNST $27.98
  • 52 Week High
  • TMDX $177.37
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 47.95
  • RNST 36.83
  • Support Level
  • TMDX $66.69
  • RNST $34.53
  • Resistance Level
  • TMDX $73.68
  • RNST $36.61
  • Average True Range (ATR)
  • TMDX 3.42
  • RNST 0.95
  • MACD
  • TMDX 0.17
  • RNST 0.10
  • Stochastic Oscillator
  • TMDX 53.89
  • RNST 16.67

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: community banks, insurance, and wealth management. With its community banks segment, the company provides a range of financial services to individuals and small businesses. Its insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The wealth management segment provides a range of services including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment. Renasant Corporation operates in the southern United States.

Share on Social Networks: